289 related articles for article (PubMed ID: 22500091)
1. Asbestos-induced cellular and molecular alteration of immunocompetent cells and their relationship with chronic inflammation and carcinogenesis.
Matsuzaki H; Maeda M; Lee S; Nishimura Y; Kumagai-Takei N; Hayashi H; Yamamoto S; Hatayama T; Kojima Y; Tabata R; Kishimoto T; Hiratsuka J; Otsuki T
J Biomed Biotechnol; 2012; 2012():492608. PubMed ID: 22500091
[TBL] [Abstract][Full Text] [Related]
2. [Immunological aspects of asbestos-related diseases].
Kanceljak-Macan B
Arh Hig Rada Toksikol; 2009 Nov; 60 Suppl():45-50. PubMed ID: 20853778
[TBL] [Abstract][Full Text] [Related]
3. [Immunological effects of silica/asbestos].
Kumagai N; Nishimura Y; Maeda M; Hayashi H; Otsuki T
Nihon Eiseigaku Zasshi; 2010 Sep; 65(4):493-9. PubMed ID: 20885075
[TBL] [Abstract][Full Text] [Related]
4. Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases.
Nishimura Y; Maeda M; Kumagai-Takei N; Lee S; Matsuzaki H; Wada Y; Nishiike-Wada T; Iguchi H; Otsuki T
Environ Health Prev Med; 2013 May; 18(3):198-204. PubMed ID: 23463177
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the immune system caused by silica and asbestos.
Maeda M; Nishimura Y; Kumagai N; Hayashi H; Hatayama T; Katoh M; Miyahara N; Yamamoto S; Hirastuka J; Otsuki T
J Immunotoxicol; 2010; 7(4):268-78. PubMed ID: 20849352
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos.
Kumagai-Takei N; Yamamoto S; Lee S; Maeda M; Masuzzaki H; Sada N; Yu M; Yoshitome K; Nishimura Y; Otsuki T
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29419731
[TBL] [Abstract][Full Text] [Related]
7. The Effects of Asbestos Fibers on Human T Cells.
Kumagai-Takei N; Lee S; Srinivas B; Shimizu Y; Sada N; Yoshitome K; Ito T; Nishimura Y; Otsuki T
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977478
[TBL] [Abstract][Full Text] [Related]
8. Diseases caused by asbestos: mechanisms of injury and disease development.
Manning CB; Vallyathan V; Mossman BT
Int Immunopharmacol; 2002 Feb; 2(2-3):191-200. PubMed ID: 11811924
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of asbestos-induced lung disease.
Liu G; Cheresh P; Kamp DW
Annu Rev Pathol; 2013 Jan; 8():161-87. PubMed ID: 23347351
[TBL] [Abstract][Full Text] [Related]
10. Expression of the T cell receptor Vbeta repertoire in a human T cell resistant to asbestos-induced apoptosis and peripheral blood T cells from patients with silica and asbestos-related diseases.
Nishimura Y; Miura Y; Maeda M; Hayashi H; Dong M; Katsuyama H; Tomita M; Hyodoh F; Kusaka M; Uesaka A; Kuribayashi K; Fukuoka K; Nakano T; Kashimoto T; Osuki T
Int J Immunopathol Pharmacol; 2006; 19(4):795-805. PubMed ID: 17166401
[TBL] [Abstract][Full Text] [Related]
11. Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients.
Maeda M; Nishimura Y; Hayashi H; Kumagai N; Chen Y; Murakami S; Miura Y; Hiratsuka J; Kishimoto T; Otsuki T
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):795-803. PubMed ID: 21357438
[TBL] [Abstract][Full Text] [Related]
12. [Respiratory malignancies induced by asbestos exposure and evaluation of cases with typical pleural malignant mesothelioma and lung cancer with asbestosis].
Kishimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Aug; 28(8):1078-84. PubMed ID: 2243458
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of CD8(+) lymphocytes in patients with pleural plaque and malignant mesothelioma.
Kumagai-Takei N; Nishimura Y; Maeda M; Hayashi H; Matsuzaki H; Lee S; Kishimoto T; Fukuoka K; Nakano T; Otsuki T
J Immunol Res; 2014; 2014():670140. PubMed ID: 25045719
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments.
Gamble JF; Gibbs GW
Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S154-86. PubMed ID: 18396365
[TBL] [Abstract][Full Text] [Related]
15. Role of asbestos in etiology of malignant pleural mesothelioma.
Godleski JJ
Thorac Surg Clin; 2004 Nov; 14(4):479-87. PubMed ID: 15559054
[TBL] [Abstract][Full Text] [Related]
16. Asbestos exposure indices.
Lippmann M
Environ Res; 1988 Jun; 46(1):86-106. PubMed ID: 3286241
[TBL] [Abstract][Full Text] [Related]
17. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers.
Kohyama N; Suzuki Y
Ann N Y Acad Sci; 1991 Dec; 643():27-52. PubMed ID: 1809139
[TBL] [Abstract][Full Text] [Related]
18. Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study.
Cvitanović S; Znaor L; Konsa T; Ivancević Z; Perić I; Erceg M; Vujović M; Vuković J; Beg-Zec Z
Croat Med J; 2003 Oct; 44(5):618-25. PubMed ID: 14515425
[TBL] [Abstract][Full Text] [Related]
19. Induction of IL-17 production from human peripheral blood CD4+ cells by asbestos exposure.
Maeda M; Chen Y; Lee S; Kumagai-Takei N; Yoshitome K; Matsuzaki H; Yamamoto S; Hatayama T; Ikeda M; Nishimura Y; Otsuki T
Int J Oncol; 2017 Jun; 50(6):2024-2032. PubMed ID: 28498408
[TBL] [Abstract][Full Text] [Related]
20. Asbestos-related lung cancer and malignant mesothelioma of the pleura: selected current issues.
Markowitz S
Semin Respir Crit Care Med; 2015 Jun; 36(3):334-46. PubMed ID: 26024342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
